Jack Stover

Jack E.
Stover was the founder of Quadrant Pharmaceuticals LLC, founded in 2013, where the title held was President & Director.
Mr. Stover is the founder of NorthView Acquisition Corp., founded in 2021, where the title held was Chief Executive Officer & Director.
Current jobs include Chief Executive Officer at Zebec Therapeutics LLC since 2014, Executive Chairman at Traws Pharma, Inc. starting in 2025, Director at Profusa, Inc. starting in 2025, and Independent Director at TransCode Therapeutics, Inc. starting in 2025.
Former jobs include President, Chief Executive Officer & Director at Antares Pharma, Inc. from 2004 to 2008; President, Chief Executive Officer & Director at Interpace Biosciences, Inc. from 2016 to 2020; Executive Chairman at Targeted Nano Therapeutics LLC from 2009 to 2012; Director at Arbios Systems, Inc. from 2005 to 2008; Director at Influmedix, Inc. from 2010 to 2011; Director at Cernostics, Inc. from 2015 to 2016; Director at Viatar CTC Solutions, Inc. in 2016; Director & Senior Vice President at B. Braun Medical, Inc.; Director & Executive Vice President at Gynetics, Inc.; Director at PDI, Inc. from 2005 to 2015; Independent Director at PharmaCyte Biotech, Inc. in 2024; Chief Financial Officer & Executive Vice President at SICOR, Inc.; Partner at PricewaterhouseCoopers LLP; and Partner at Coopers & Lybrand LLP.
Education includes undergraduate studies at Lehigh University.